Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mutation | 111 | 2024 | 30266 | 2.110 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 24 | 2023 | 1642 | 2.020 |
Why?
|
Genome, Human | 40 | 2021 | 4456 | 1.660 |
Why?
|
Neoplasms | 48 | 2023 | 22390 | 1.560 |
Why?
|
High-Throughput Nucleotide Sequencing | 26 | 2022 | 3671 | 1.530 |
Why?
|
DNA Mutational Analysis | 24 | 2020 | 4123 | 1.450 |
Why?
|
Genes, Neoplasm | 8 | 2018 | 371 | 1.440 |
Why?
|
Genomics | 38 | 2023 | 5928 | 1.330 |
Why?
|
Multiple Myeloma | 19 | 2025 | 5195 | 1.330 |
Why?
|
Sequence Analysis, DNA | 28 | 2020 | 4784 | 1.290 |
Why?
|
Software | 11 | 2022 | 4480 | 1.090 |
Why?
|
Sequence Analysis, RNA | 12 | 2022 | 2041 | 1.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 37 | 2024 | 8664 | 0.960 |
Why?
|
Drug Resistance, Neoplasm | 30 | 2023 | 5342 | 0.920 |
Why?
|
DNA Damage | 8 | 2020 | 2472 | 0.900 |
Why?
|
DNA Copy Number Variations | 26 | 2022 | 2055 | 0.830 |
Why?
|
Microsatellite Repeats | 4 | 2019 | 785 | 0.780 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 10 | 2023 | 1437 | 0.760 |
Why?
|
Mutagenesis | 6 | 2020 | 1229 | 0.760 |
Why?
|
Gene Dosage | 14 | 2020 | 1222 | 0.750 |
Why?
|
INDEL Mutation | 3 | 2020 | 267 | 0.710 |
Why?
|
Lung Neoplasms | 25 | 2024 | 13593 | 0.690 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 3 | 2020 | 106 | 0.670 |
Why?
|
DNA Polymerase II | 2 | 2018 | 104 | 0.630 |
Why?
|
Melanoma | 17 | 2023 | 5709 | 0.630 |
Why?
|
Oncogenes | 9 | 2022 | 1236 | 0.620 |
Why?
|
Artifacts | 3 | 2018 | 1942 | 0.610 |
Why?
|
DNA, Neoplasm | 7 | 2019 | 1748 | 0.610 |
Why?
|
Point Mutation | 8 | 2017 | 1595 | 0.610 |
Why?
|
DNA Polymerase III | 1 | 2018 | 52 | 0.600 |
Why?
|
Databases, Genetic | 10 | 2020 | 1758 | 0.580 |
Why?
|
Oncogene Proteins | 4 | 2020 | 718 | 0.580 |
Why?
|
Genetic Heterogeneity | 7 | 2019 | 737 | 0.550 |
Why?
|
Humans | 236 | 2025 | 768887 | 0.520 |
Why?
|
Neoplastic Cells, Circulating | 6 | 2023 | 957 | 0.500 |
Why?
|
Carcinoma, Squamous Cell | 10 | 2023 | 4064 | 0.490 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 3 | 2022 | 179 | 0.480 |
Why?
|
DNA Mismatch Repair | 1 | 2018 | 432 | 0.480 |
Why?
|
Adenocarcinoma | 16 | 2023 | 6401 | 0.470 |
Why?
|
Cell Line, Tumor | 41 | 2024 | 17174 | 0.470 |
Why?
|
Urinary Bladder Neoplasms | 5 | 2020 | 2250 | 0.470 |
Why?
|
DNA Repair | 7 | 2020 | 2054 | 0.460 |
Why?
|
Protein Kinase Inhibitors | 20 | 2023 | 5707 | 0.450 |
Why?
|
RNA | 3 | 2022 | 2727 | 0.450 |
Why?
|
Models, Genetic | 6 | 2019 | 3446 | 0.450 |
Why?
|
Germ-Line Mutation | 9 | 2024 | 1887 | 0.440 |
Why?
|
Breast Neoplasms | 14 | 2024 | 21187 | 0.440 |
Why?
|
Chromosome Aberrations | 10 | 2018 | 1780 | 0.420 |
Why?
|
Evolution, Molecular | 7 | 2019 | 1894 | 0.410 |
Why?
|
Tumor Suppressor Protein p53 | 15 | 2020 | 2960 | 0.400 |
Why?
|
Proto-Oncogene Proteins B-raf | 11 | 2023 | 2059 | 0.400 |
Why?
|
Mutation, Missense | 5 | 2016 | 2592 | 0.390 |
Why?
|
Gene Expression Profiling | 22 | 2022 | 9549 | 0.390 |
Why?
|
DNA, Mitochondrial | 3 | 2024 | 871 | 0.390 |
Why?
|
Gene Amplification | 9 | 2016 | 1099 | 0.380 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 3 | 2019 | 213 | 0.370 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 9 | 2024 | 5434 | 0.370 |
Why?
|
Quality Control | 3 | 2021 | 836 | 0.370 |
Why?
|
MAP Kinase Signaling System | 5 | 2021 | 1494 | 0.350 |
Why?
|
Antigens, Neoplasm | 8 | 2021 | 2001 | 0.350 |
Why?
|
Clone Cells | 8 | 2021 | 1670 | 0.340 |
Why?
|
Phosphatidylinositol 3-Kinases | 10 | 2024 | 2884 | 0.340 |
Why?
|
Tumor Suppressor Proteins | 5 | 2018 | 2813 | 0.340 |
Why?
|
Genetic Techniques | 1 | 2012 | 428 | 0.320 |
Why?
|
Molecular Targeted Therapy | 9 | 2023 | 2830 | 0.320 |
Why?
|
Endometrial Neoplasms | 4 | 2018 | 1386 | 0.310 |
Why?
|
Genomic Instability | 6 | 2023 | 715 | 0.310 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1483 | 0.310 |
Why?
|
Cell Transformation, Neoplastic | 7 | 2022 | 2848 | 0.310 |
Why?
|
Cytidine Deaminase | 2 | 2023 | 249 | 0.300 |
Why?
|
Disease Progression | 18 | 2025 | 13677 | 0.300 |
Why?
|
Glioblastoma | 6 | 2023 | 3525 | 0.290 |
Why?
|
Promoter Regions, Genetic | 3 | 2018 | 5801 | 0.290 |
Why?
|
Antineoplastic Agents | 16 | 2023 | 13699 | 0.280 |
Why?
|
Genetic Predisposition to Disease | 18 | 2024 | 18065 | 0.280 |
Why?
|
Consensus Sequence | 1 | 2007 | 363 | 0.280 |
Why?
|
Computational Biology | 8 | 2017 | 3562 | 0.280 |
Why?
|
Neoplasm Proteins | 7 | 2021 | 3608 | 0.280 |
Why?
|
Precancerous Conditions | 2 | 2023 | 985 | 0.260 |
Why?
|
Genetic Variation | 7 | 2018 | 6610 | 0.260 |
Why?
|
Barrett Esophagus | 2 | 2023 | 495 | 0.260 |
Why?
|
Genes, Tumor Suppressor | 4 | 2019 | 1064 | 0.260 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2016 | 478 | 0.250 |
Why?
|
DNA | 4 | 2019 | 7214 | 0.250 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 10 | 2025 | 11886 | 0.250 |
Why?
|
Colorectal Neoplasms | 6 | 2023 | 6982 | 0.240 |
Why?
|
DNA Replication | 3 | 2018 | 1428 | 0.230 |
Why?
|
Brain Neoplasms | 8 | 2020 | 9213 | 0.230 |
Why?
|
Single-Cell Analysis | 7 | 2024 | 2542 | 0.230 |
Why?
|
Neoplasm Metastasis | 11 | 2019 | 4926 | 0.230 |
Why?
|
Dual Specificity Phosphatase 6 | 2 | 2021 | 12 | 0.230 |
Why?
|
Microsatellite Instability | 2 | 2019 | 726 | 0.230 |
Why?
|
Genome-Wide Association Study | 16 | 2022 | 12798 | 0.230 |
Why?
|
Lactams, Macrocyclic | 2 | 2016 | 319 | 0.230 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 6 | 2024 | 906 | 0.230 |
Why?
|
Cell Proliferation | 14 | 2022 | 10486 | 0.220 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 2 | 2016 | 168 | 0.220 |
Why?
|
Esophageal Neoplasms | 3 | 2023 | 1674 | 0.220 |
Why?
|
Plasma Cells | 3 | 2022 | 599 | 0.220 |
Why?
|
Boron Compounds | 1 | 2025 | 196 | 0.210 |
Why?
|
Female | 72 | 2025 | 397464 | 0.210 |
Why?
|
Gene Regulatory Networks | 5 | 2018 | 1752 | 0.210 |
Why?
|
Cluster Analysis | 8 | 2021 | 2730 | 0.210 |
Why?
|
Transplantation, Autologous | 3 | 2023 | 2126 | 0.210 |
Why?
|
Liposarcoma | 2 | 2019 | 289 | 0.210 |
Why?
|
Alleles | 7 | 2018 | 6901 | 0.200 |
Why?
|
Cholangiocarcinoma | 2 | 2019 | 562 | 0.200 |
Why?
|
DNA Methylation | 6 | 2020 | 4432 | 0.200 |
Why?
|
Phosphoproteins | 4 | 2020 | 2452 | 0.200 |
Why?
|
Sample Size | 3 | 2016 | 848 | 0.200 |
Why?
|
Tumor Microenvironment | 9 | 2023 | 3951 | 0.200 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2024 | 5716 | 0.200 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2021 | 47 | 0.200 |
Why?
|
Neoplasms, Squamous Cell | 2 | 2013 | 95 | 0.200 |
Why?
|
Craniopharyngioma | 2 | 2015 | 279 | 0.200 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2021 | 71 | 0.190 |
Why?
|
Guanine Nucleotide Exchange Factors | 2 | 2018 | 572 | 0.190 |
Why?
|
Cancer Vaccines | 3 | 2018 | 1042 | 0.190 |
Why?
|
Cohort Studies | 17 | 2022 | 41800 | 0.190 |
Why?
|
Translocation, Genetic | 4 | 2016 | 1395 | 0.190 |
Why?
|
Algorithms | 12 | 2022 | 14199 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2022 | 9442 | 0.190 |
Why?
|
Glycine | 1 | 2025 | 672 | 0.190 |
Why?
|
Immunoglobulin Variable Region | 1 | 2022 | 420 | 0.190 |
Why?
|
Mosaicism | 1 | 2024 | 481 | 0.180 |
Why?
|
Base Sequence | 11 | 2023 | 12430 | 0.180 |
Why?
|
Carcinoma | 3 | 2019 | 2340 | 0.180 |
Why?
|
Tachykinins | 1 | 2021 | 77 | 0.180 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2024 | 1363 | 0.180 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 58 | 0.180 |
Why?
|
Male | 62 | 2025 | 365249 | 0.180 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2024 | 592 | 0.180 |
Why?
|
Osteosarcoma | 2 | 2018 | 911 | 0.180 |
Why?
|
Antibodies, Bispecific | 1 | 2023 | 205 | 0.180 |
Why?
|
Organ Specificity | 3 | 2022 | 1970 | 0.170 |
Why?
|
Enhancer Elements, Genetic | 2 | 2024 | 1369 | 0.170 |
Why?
|
Genes, p53 | 2 | 2012 | 716 | 0.170 |
Why?
|
Repressor Proteins | 3 | 2021 | 2986 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2023 | 1408 | 0.170 |
Why?
|
Protein Structure, Tertiary | 7 | 2015 | 3775 | 0.170 |
Why?
|
False Positive Reactions | 2 | 2013 | 963 | 0.170 |
Why?
|
Reed-Sternberg Cells | 1 | 2019 | 78 | 0.170 |
Why?
|
Prenylation | 1 | 2019 | 37 | 0.170 |
Why?
|
Gene Deletion | 3 | 2019 | 2674 | 0.170 |
Why?
|
Genetic Loci | 3 | 2018 | 2630 | 0.170 |
Why?
|
Transferrin | 1 | 2020 | 284 | 0.170 |
Why?
|
Apyrase | 2 | 2019 | 376 | 0.160 |
Why?
|
Isocitrate Dehydrogenase | 3 | 2017 | 958 | 0.160 |
Why?
|
Bone Neoplasms | 3 | 2018 | 2565 | 0.160 |
Why?
|
Signal Transduction | 21 | 2021 | 23652 | 0.160 |
Why?
|
Immunotherapy | 5 | 2023 | 4755 | 0.160 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2020 | 1616 | 0.160 |
Why?
|
Dexamethasone | 2 | 2025 | 1965 | 0.160 |
Why?
|
Mediastinal Neoplasms | 2 | 2019 | 403 | 0.160 |
Why?
|
Chromosome Deletion | 5 | 2016 | 1390 | 0.160 |
Why?
|
Glioma | 4 | 2018 | 3532 | 0.160 |
Why?
|
Paraproteinemias | 1 | 2022 | 252 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2024 | 998 | 0.160 |
Why?
|
E2F Transcription Factors | 2 | 2017 | 270 | 0.160 |
Why?
|
RNA Splicing | 4 | 2021 | 905 | 0.160 |
Why?
|
Multigene Family | 3 | 2018 | 1082 | 0.160 |
Why?
|
Lipogenesis | 1 | 2020 | 216 | 0.160 |
Why?
|
Receptors, Aryl Hydrocarbon | 2 | 2019 | 221 | 0.160 |
Why?
|
Head and Neck Neoplasms | 3 | 2023 | 2931 | 0.160 |
Why?
|
Contact Inhibition | 1 | 2018 | 46 | 0.160 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2016 | 1629 | 0.150 |
Why?
|
Pyrimidines | 7 | 2023 | 3050 | 0.150 |
Why?
|
Kynurenine | 1 | 2019 | 142 | 0.150 |
Why?
|
Protein Binding | 5 | 2021 | 9344 | 0.150 |
Why?
|
Transplantation, Homologous | 2 | 2024 | 4835 | 0.150 |
Why?
|
B-Lymphocytes | 5 | 2023 | 4794 | 0.150 |
Why?
|
Poisson Distribution | 1 | 2019 | 508 | 0.150 |
Why?
|
Myelodysplastic Syndromes | 2 | 2021 | 1399 | 0.150 |
Why?
|
Retinoblastoma Protein | 3 | 2020 | 673 | 0.150 |
Why?
|
Bayes Theorem | 4 | 2018 | 2357 | 0.150 |
Why?
|
Estrogen Receptor alpha | 2 | 2020 | 581 | 0.150 |
Why?
|
Cyclin E | 2 | 2020 | 156 | 0.150 |
Why?
|
DNA-Binding Proteins | 9 | 2020 | 9618 | 0.150 |
Why?
|
Ploidies | 3 | 2013 | 287 | 0.150 |
Why?
|
Mitochondria | 3 | 2020 | 3683 | 0.150 |
Why?
|
Neoplasms, Experimental | 3 | 2019 | 1231 | 0.150 |
Why?
|
Camptothecin | 1 | 2021 | 600 | 0.150 |
Why?
|
Computer Graphics | 1 | 2019 | 344 | 0.150 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 247 | 0.150 |
Why?
|
Genomic Structural Variation | 1 | 2018 | 80 | 0.140 |
Why?
|
Bone Marrow | 3 | 2023 | 2935 | 0.140 |
Why?
|
Gene Rearrangement | 7 | 2018 | 1148 | 0.140 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2019 | 1756 | 0.140 |
Why?
|
Quinazolines | 3 | 2016 | 1373 | 0.140 |
Why?
|
Alternative Splicing | 3 | 2019 | 1105 | 0.140 |
Why?
|
Dog Diseases | 1 | 2018 | 143 | 0.140 |
Why?
|
Ovarian Neoplasms | 5 | 2014 | 4919 | 0.140 |
Why?
|
Phenotype | 13 | 2023 | 16735 | 0.140 |
Why?
|
Dogs | 3 | 2018 | 3845 | 0.140 |
Why?
|
Allelic Imbalance | 1 | 2017 | 77 | 0.140 |
Why?
|
Phenylurea Compounds | 2 | 2019 | 531 | 0.140 |
Why?
|
Middle Aged | 40 | 2025 | 223740 | 0.140 |
Why?
|
Neoplasm, Residual | 2 | 2020 | 1019 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 3 | 2015 | 394 | 0.140 |
Why?
|
Models, Molecular | 7 | 2016 | 5404 | 0.140 |
Why?
|
Hematopoiesis | 3 | 2021 | 2059 | 0.140 |
Why?
|
Nuclear Proteins | 5 | 2021 | 5803 | 0.140 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2017 | 165 | 0.140 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 2 | 2016 | 109 | 0.140 |
Why?
|
Aged, 80 and over | 20 | 2025 | 59738 | 0.140 |
Why?
|
Disease | 1 | 2022 | 673 | 0.140 |
Why?
|
CA-125 Antigen | 1 | 2019 | 281 | 0.140 |
Why?
|
Prostate-Specific Antigen | 3 | 2021 | 2487 | 0.130 |
Why?
|
MicroRNAs | 6 | 2019 | 3811 | 0.130 |
Why?
|
Chromatin | 5 | 2021 | 2981 | 0.130 |
Why?
|
Catalytic Domain | 2 | 2015 | 699 | 0.130 |
Why?
|
beta Catenin | 4 | 2014 | 1047 | 0.130 |
Why?
|
T-Lymphocytes | 5 | 2023 | 10276 | 0.130 |
Why?
|
Genes, X-Linked | 1 | 2016 | 129 | 0.130 |
Why?
|
Pituitary Neoplasms | 2 | 2015 | 1326 | 0.130 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2019 | 1769 | 0.130 |
Why?
|
Astrocytoma | 1 | 2020 | 780 | 0.130 |
Why?
|
Adult | 37 | 2025 | 223818 | 0.130 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2019 | 547 | 0.130 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2018 | 701 | 0.130 |
Why?
|
Sulfonamides | 4 | 2019 | 1982 | 0.130 |
Why?
|
Epigenesis, Genetic | 6 | 2024 | 3836 | 0.130 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2014 | 2063 | 0.130 |
Why?
|
Reproducibility of Results | 8 | 2021 | 20244 | 0.120 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2023 | 1376 | 0.120 |
Why?
|
Endometrial Hyperplasia | 1 | 2016 | 102 | 0.120 |
Why?
|
Prognosis | 10 | 2022 | 30044 | 0.120 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 1966 | 0.120 |
Why?
|
Transcription, Genetic | 4 | 2018 | 7609 | 0.120 |
Why?
|
Cell Cycle Proteins | 6 | 2016 | 3450 | 0.120 |
Why?
|
Genes, p16 | 2 | 2012 | 159 | 0.120 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2211 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2020 | 803 | 0.120 |
Why?
|
Stem Cell Transplantation | 1 | 2023 | 1602 | 0.120 |
Why?
|
GTPase-Activating Proteins | 1 | 2018 | 469 | 0.120 |
Why?
|
Leiomyosarcoma | 1 | 2019 | 425 | 0.120 |
Why?
|
Janus Kinase 3 | 1 | 2015 | 76 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1625 | 0.120 |
Why?
|
Aged | 31 | 2025 | 171790 | 0.120 |
Why?
|
Exons | 5 | 2012 | 2395 | 0.120 |
Why?
|
Oligodendroglioma | 1 | 2016 | 278 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 2004 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2014 | 3811 | 0.120 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2016 | 419 | 0.120 |
Why?
|
Angiomyolipoma | 1 | 2016 | 189 | 0.120 |
Why?
|
Immune Evasion | 2 | 2019 | 376 | 0.120 |
Why?
|
Selection, Genetic | 1 | 2019 | 878 | 0.120 |
Why?
|
Loss of Heterozygosity | 5 | 2017 | 663 | 0.120 |
Why?
|
Antigen Presentation | 2 | 2017 | 1252 | 0.120 |
Why?
|
Abdominal Neoplasms | 1 | 2016 | 287 | 0.120 |
Why?
|
Chromosomes, Human, X | 1 | 2016 | 321 | 0.120 |
Why?
|
Phosphorylation | 7 | 2023 | 8317 | 0.120 |
Why?
|
X Chromosome Inactivation | 1 | 2016 | 229 | 0.120 |
Why?
|
Pulmonary Blastoma | 1 | 2014 | 43 | 0.120 |
Why?
|
Pelvic Neoplasms | 1 | 2016 | 250 | 0.110 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2016 | 207 | 0.110 |
Why?
|
Genes, BRCA2 | 1 | 2017 | 593 | 0.110 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 1560 | 0.110 |
Why?
|
Papillomavirus Infections | 3 | 2023 | 1640 | 0.110 |
Why?
|
Oligodendroglia | 1 | 2018 | 540 | 0.110 |
Why?
|
DEAD-box RNA Helicases | 2 | 2014 | 385 | 0.110 |
Why?
|
Uveal Neoplasms | 1 | 2017 | 344 | 0.110 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 183 | 0.110 |
Why?
|
Kidney Neoplasms | 2 | 2024 | 4300 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 4 | 2023 | 637 | 0.110 |
Why?
|
Genes, BRCA1 | 1 | 2017 | 756 | 0.110 |
Why?
|
Prostatic Neoplasms | 5 | 2021 | 11229 | 0.110 |
Why?
|
Immunoconjugates | 1 | 2021 | 976 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2020 | 1156 | 0.110 |
Why?
|
DNA Replication Timing | 1 | 2013 | 35 | 0.110 |
Why?
|
Pyrazoles | 4 | 2019 | 2029 | 0.110 |
Why?
|
Apoptosis | 8 | 2019 | 9528 | 0.110 |
Why?
|
Receptors, Estrogen | 2 | 2022 | 2252 | 0.110 |
Why?
|
Databases, Protein | 1 | 2015 | 390 | 0.110 |
Why?
|
Cell Nucleus | 1 | 2022 | 2885 | 0.110 |
Why?
|
Tongue Neoplasms | 1 | 2015 | 186 | 0.110 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2014 | 719 | 0.110 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2018 | 664 | 0.110 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 2 | 2018 | 368 | 0.110 |
Why?
|
Receptor, erbB-2 | 4 | 2022 | 2606 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2013 | 185 | 0.110 |
Why?
|
Polyploidy | 1 | 2013 | 120 | 0.110 |
Why?
|
Thyroid Neoplasms | 2 | 2018 | 2360 | 0.110 |
Why?
|
Biological Products | 1 | 2022 | 944 | 0.110 |
Why?
|
RNA, Messenger | 3 | 2017 | 12809 | 0.110 |
Why?
|
Retroelements | 1 | 2014 | 163 | 0.100 |
Why?
|
Tumor Burden | 1 | 2019 | 1913 | 0.100 |
Why?
|
Testicular Neoplasms | 2 | 2016 | 805 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 12 | 2018 | 16051 | 0.100 |
Why?
|
Animals | 29 | 2023 | 169408 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 2003 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 317 | 0.100 |
Why?
|
Anus Neoplasms | 1 | 2016 | 336 | 0.100 |
Why?
|
Cell Hypoxia | 1 | 2015 | 662 | 0.100 |
Why?
|
Sirtuins | 1 | 2015 | 322 | 0.100 |
Why?
|
Proteomics | 2 | 2023 | 3913 | 0.100 |
Why?
|
Androgen Antagonists | 1 | 2021 | 1421 | 0.100 |
Why?
|
Gene Library | 2 | 2012 | 1062 | 0.100 |
Why?
|
Encyclopedias as Topic | 1 | 2012 | 19 | 0.100 |
Why?
|
Computer Simulation | 3 | 2018 | 6289 | 0.100 |
Why?
|
Genomic Library | 1 | 2012 | 189 | 0.100 |
Why?
|
Transcription Factors | 9 | 2021 | 12174 | 0.100 |
Why?
|
Urothelium | 1 | 2014 | 276 | 0.100 |
Why?
|
Ribonuclease III | 1 | 2014 | 271 | 0.100 |
Why?
|
Protein Biosynthesis | 2 | 2017 | 2094 | 0.100 |
Why?
|
Cisplatin | 2 | 2017 | 1661 | 0.100 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2019 | 798 | 0.100 |
Why?
|
Cell Survival | 8 | 2016 | 5794 | 0.100 |
Why?
|
Qb-SNARE Proteins | 1 | 2011 | 34 | 0.100 |
Why?
|
Neoplastic Stem Cells | 2 | 2017 | 1356 | 0.100 |
Why?
|
Protein Interaction Mapping | 1 | 2015 | 621 | 0.100 |
Why?
|
Receptors, Androgen | 1 | 2018 | 1091 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 957 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2021 | 2460 | 0.100 |
Why?
|
Guanine | 1 | 2013 | 280 | 0.100 |
Why?
|
Antigens, CD | 2 | 2019 | 4032 | 0.090 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 493 | 0.090 |
Why?
|
ROC Curve | 1 | 2019 | 3629 | 0.090 |
Why?
|
Aneuploidy | 2 | 2012 | 573 | 0.090 |
Why?
|
Urinary Bladder | 1 | 2017 | 1162 | 0.090 |
Why?
|
Spliceosomes | 1 | 2011 | 116 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2023 | 4651 | 0.090 |
Why?
|
Ribonucleoproteins | 1 | 2014 | 359 | 0.090 |
Why?
|
Genome, Fungal | 1 | 2012 | 203 | 0.090 |
Why?
|
Internet | 2 | 2015 | 3112 | 0.090 |
Why?
|
Quantitative Trait Loci | 1 | 2019 | 2133 | 0.090 |
Why?
|
Pyrimidinones | 3 | 2023 | 386 | 0.090 |
Why?
|
Cell Division | 1 | 2018 | 4478 | 0.090 |
Why?
|
RNA, Ribosomal | 1 | 2012 | 227 | 0.090 |
Why?
|
Bile Duct Neoplasms | 1 | 2016 | 615 | 0.090 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2011 | 153 | 0.090 |
Why?
|
Intestinal Neoplasms | 1 | 2013 | 314 | 0.090 |
Why?
|
Gene Silencing | 1 | 2017 | 1505 | 0.090 |
Why?
|
Pancreatic Neoplasms | 2 | 2019 | 5443 | 0.090 |
Why?
|
Rhabdomyosarcoma | 1 | 2014 | 358 | 0.090 |
Why?
|
Cell Cycle | 3 | 2016 | 2937 | 0.090 |
Why?
|
Neurofibromin 1 | 1 | 2012 | 190 | 0.090 |
Why?
|
Pathology, Clinical | 1 | 2014 | 377 | 0.090 |
Why?
|
Gene Fusion | 4 | 2016 | 357 | 0.090 |
Why?
|
Genetic Markers | 3 | 2018 | 2604 | 0.090 |
Why?
|
Urologic Neoplasms | 1 | 2014 | 318 | 0.090 |
Why?
|
Chromosome Mapping | 2 | 2016 | 4624 | 0.090 |
Why?
|
Mice | 17 | 2023 | 82074 | 0.090 |
Why?
|
Ultraviolet Rays | 2 | 2012 | 1104 | 0.090 |
Why?
|
Sunlight | 1 | 2012 | 337 | 0.090 |
Why?
|
Schizosaccharomyces | 1 | 2012 | 236 | 0.090 |
Why?
|
Neuroendocrine Tumors | 2 | 2013 | 657 | 0.090 |
Why?
|
Rhabdoid Tumor | 1 | 2012 | 211 | 0.090 |
Why?
|
Biotechnology | 1 | 2012 | 283 | 0.090 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2010 | 54 | 0.090 |
Why?
|
Cell Separation | 2 | 2014 | 1728 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2023 | 11934 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 4 | 2020 | 4528 | 0.090 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2013 | 792 | 0.080 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2015 | 454 | 0.080 |
Why?
|
Acetylation | 2 | 2023 | 1056 | 0.080 |
Why?
|
Enzyme Activation | 3 | 2021 | 3588 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 8055 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2018 | 2911 | 0.080 |
Why?
|
RNA Interference | 5 | 2019 | 2835 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 4593 | 0.080 |
Why?
|
Membrane Proteins | 4 | 2021 | 7885 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2020 | 710 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2024 | 3200 | 0.080 |
Why?
|
Skin Neoplasms | 3 | 2013 | 5864 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 945 | 0.080 |
Why?
|
Oximes | 3 | 2015 | 303 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1891 | 0.080 |
Why?
|
Gene Expression | 4 | 2015 | 7602 | 0.080 |
Why?
|
Cells, Cultured | 7 | 2020 | 19023 | 0.080 |
Why?
|
Pyridones | 3 | 2023 | 819 | 0.080 |
Why?
|
Trans-Activators | 2 | 2019 | 2858 | 0.080 |
Why?
|
Receptor, Notch1 | 1 | 2011 | 520 | 0.080 |
Why?
|
Histones | 4 | 2023 | 2603 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2022 | 314 | 0.070 |
Why?
|
Graft vs Host Disease | 1 | 2020 | 3048 | 0.070 |
Why?
|
HEK293 Cells | 5 | 2014 | 4291 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2014 | 2359 | 0.070 |
Why?
|
Pyridines | 2 | 2018 | 2896 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3626 | 0.070 |
Why?
|
Sirolimus | 1 | 2014 | 1540 | 0.070 |
Why?
|
Cerebellar Neoplasms | 1 | 2012 | 591 | 0.070 |
Why?
|
PTEN Phosphohydrolase | 4 | 2018 | 1120 | 0.070 |
Why?
|
Homozygote | 1 | 2012 | 1779 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 930 | 0.070 |
Why?
|
Genome, Bacterial | 1 | 2012 | 796 | 0.070 |
Why?
|
Cell Line | 5 | 2021 | 15603 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1541 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2013 | 2892 | 0.070 |
Why?
|
Medulloblastoma | 1 | 2012 | 683 | 0.070 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2012 | 724 | 0.070 |
Why?
|
Amino Acid Sequence | 5 | 2019 | 13427 | 0.070 |
Why?
|
Macrophages | 2 | 2019 | 5800 | 0.070 |
Why?
|
Case-Control Studies | 5 | 2019 | 22294 | 0.070 |
Why?
|
Oxidation-Reduction | 1 | 2013 | 2226 | 0.070 |
Why?
|
DNA Breaks, Double-Stranded | 2 | 2023 | 608 | 0.070 |
Why?
|
Molecular Sequence Data | 6 | 2015 | 17629 | 0.070 |
Why?
|
Treatment Outcome | 11 | 2025 | 65485 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2018 | 3701 | 0.070 |
Why?
|
Heterozygote | 1 | 2013 | 2798 | 0.060 |
Why?
|
Genotype | 4 | 2018 | 13048 | 0.060 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2007 | 361 | 0.060 |
Why?
|
Cell Lineage | 3 | 2017 | 2576 | 0.060 |
Why?
|
Genome | 2 | 2011 | 1752 | 0.060 |
Why?
|
Databases, Nucleic Acid | 2 | 2019 | 204 | 0.060 |
Why?
|
Neoadjuvant Therapy | 4 | 2021 | 2909 | 0.060 |
Why?
|
Genes, myc | 2 | 2018 | 391 | 0.060 |
Why?
|
Mice, Nude | 4 | 2014 | 3631 | 0.060 |
Why?
|
CDC2-CDC28 Kinases | 2 | 2016 | 111 | 0.060 |
Why?
|
Lactams | 2 | 2016 | 159 | 0.060 |
Why?
|
Probability | 2 | 2007 | 2483 | 0.060 |
Why?
|
NIH 3T3 Cells | 3 | 2013 | 669 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1248 | 0.060 |
Why?
|
GTP Phosphohydrolases | 2 | 2021 | 524 | 0.060 |
Why?
|
Neurofibromatosis 1 | 1 | 2010 | 561 | 0.060 |
Why?
|
Sequence Alignment | 3 | 2015 | 2179 | 0.060 |
Why?
|
Phylogeny | 3 | 2016 | 2843 | 0.060 |
Why?
|
Neuroblastoma | 1 | 2013 | 1266 | 0.060 |
Why?
|
Mass Spectrometry | 2 | 2022 | 2204 | 0.060 |
Why?
|
User-Computer Interface | 2 | 2013 | 1406 | 0.060 |
Why?
|
Gene Frequency | 3 | 2017 | 3625 | 0.060 |
Why?
|
Imidazoles | 3 | 2015 | 1169 | 0.060 |
Why?
|
Meningioma | 1 | 2013 | 1226 | 0.060 |
Why?
|
Virus Integration | 2 | 2018 | 307 | 0.060 |
Why?
|
Flow Cytometry | 2 | 2012 | 5905 | 0.050 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2021 | 615 | 0.050 |
Why?
|
Immunologic Memory | 2 | 2024 | 1378 | 0.050 |
Why?
|
Chemokine CCL4 | 1 | 2023 | 127 | 0.050 |
Why?
|
Core Binding Factor beta Subunit | 2 | 2013 | 42 | 0.050 |
Why?
|
Sulfones | 2 | 2016 | 448 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9264 | 0.050 |
Why?
|
Interferon Regulatory Factors | 1 | 2024 | 271 | 0.050 |
Why?
|
Transcriptional Activation | 2 | 2022 | 1750 | 0.050 |
Why?
|
F-Box Proteins | 2 | 2015 | 201 | 0.050 |
Why?
|
Tumor Cells, Cultured | 3 | 2019 | 6131 | 0.050 |
Why?
|
Neoplasm Invasiveness | 3 | 2017 | 3629 | 0.050 |
Why?
|
Chromosomal Instability | 1 | 2023 | 176 | 0.050 |
Why?
|
MAP Kinase Kinase 1 | 2 | 2015 | 331 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2012 | 3414 | 0.050 |
Why?
|
Models, Theoretical | 2 | 2011 | 3580 | 0.050 |
Why?
|
HLA Antigens | 2 | 2020 | 1336 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2020 | 1608 | 0.050 |
Why?
|
Mice, Inbred C57BL | 5 | 2019 | 22381 | 0.050 |
Why?
|
Immunotherapy, Adoptive | 2 | 2022 | 1519 | 0.050 |
Why?
|
Aminopyridines | 2 | 2016 | 580 | 0.050 |
Why?
|
Paired Box Transcription Factors | 2 | 2014 | 206 | 0.050 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2021 | 1535 | 0.050 |
Why?
|
Chromosome Breakpoints | 2 | 2012 | 93 | 0.050 |
Why?
|
Hematologic Neoplasms | 1 | 2013 | 1907 | 0.050 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2021 | 43 | 0.050 |
Why?
|
Protein Conformation | 3 | 2014 | 3956 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2013 | 2044 | 0.050 |
Why?
|
Workflow | 2 | 2019 | 859 | 0.050 |
Why?
|
Dimerization | 2 | 2013 | 886 | 0.050 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2021 | 178 | 0.050 |
Why?
|
bcl-X Protein | 2 | 2015 | 412 | 0.050 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2013 | 379 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2015 | 1903 | 0.050 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2014 | 658 | 0.050 |
Why?
|
Cell Adhesion Molecules | 2 | 2021 | 1614 | 0.050 |
Why?
|
raf Kinases | 2 | 2013 | 117 | 0.050 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2024 | 1356 | 0.040 |
Why?
|
Sequence Deletion | 2 | 2018 | 1498 | 0.040 |
Why?
|
Information Storage and Retrieval | 1 | 2006 | 831 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12873 | 0.040 |
Why?
|
Graft vs Leukemia Effect | 1 | 2020 | 121 | 0.040 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2016 | 2525 | 0.040 |
Why?
|
Recurrence | 3 | 2019 | 8512 | 0.040 |
Why?
|
DNA Breaks | 1 | 2020 | 47 | 0.040 |
Why?
|
Escherichia coli | 1 | 2012 | 4212 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2022 | 640 | 0.040 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2021 | 303 | 0.040 |
Why?
|
Risk | 2 | 2022 | 9621 | 0.040 |
Why?
|
Quinazolinones | 1 | 2021 | 219 | 0.040 |
Why?
|
High-Throughput Screening Assays | 2 | 2016 | 941 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14751 | 0.040 |
Why?
|
Nucleic Acid Conformation | 2 | 2014 | 901 | 0.040 |
Why?
|
Methylation | 2 | 2013 | 1078 | 0.040 |
Why?
|
Antigens, CD19 | 1 | 2022 | 446 | 0.040 |
Why?
|
Sequence Homology | 1 | 2019 | 199 | 0.040 |
Why?
|
Open Reading Frames | 2 | 2014 | 818 | 0.040 |
Why?
|
Sarcoma | 1 | 2010 | 1806 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2023 | 18366 | 0.040 |
Why?
|
Melanocytes | 2 | 2012 | 509 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2019 | 3621 | 0.040 |
Why?
|
Automation | 1 | 2021 | 589 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 808 | 0.040 |
Why?
|
Chromosomes, Human | 2 | 2012 | 438 | 0.040 |
Why?
|
Haploidy | 1 | 2018 | 127 | 0.040 |
Why?
|
Melanoma, Experimental | 1 | 2021 | 559 | 0.040 |
Why?
|
Proteome | 2 | 2020 | 1891 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2021 | 354 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2018 | 72 | 0.040 |
Why?
|
CpG Islands | 2 | 2014 | 1210 | 0.040 |
Why?
|
Young Adult | 6 | 2022 | 60110 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2019 | 369 | 0.040 |
Why?
|
Founder Effect | 1 | 2018 | 185 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
DNA Modification Methylases | 1 | 2018 | 210 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 352 | 0.040 |
Why?
|
Purines | 1 | 2021 | 615 | 0.040 |
Why?
|
Time-Lapse Imaging | 1 | 2018 | 194 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2019 | 344 | 0.040 |
Why?
|
Eukaryotic Initiation Factor-1 | 1 | 2017 | 31 | 0.040 |
Why?
|
Phthalazines | 1 | 2020 | 397 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 566 | 0.040 |
Why?
|
Protein Array Analysis | 1 | 2019 | 400 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2015 | 1803 | 0.040 |
Why?
|
Blotting, Western | 2 | 2016 | 5035 | 0.040 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2018 | 247 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2015 | 4862 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 501 | 0.040 |
Why?
|
Transcription Factor TFIIIA | 1 | 2016 | 24 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2019 | 11262 | 0.040 |
Why?
|
Cell Shape | 1 | 2018 | 371 | 0.040 |
Why?
|
Gene Duplication | 1 | 2018 | 315 | 0.030 |
Why?
|
DNA Repair Enzymes | 1 | 2018 | 346 | 0.030 |
Why?
|
beta 2-Microglobulin | 1 | 2017 | 330 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2018 | 350 | 0.030 |
Why?
|
Ubiquitination | 1 | 2021 | 1010 | 0.030 |
Why?
|
Cell Death | 1 | 2022 | 1682 | 0.030 |
Why?
|
rho-Associated Kinases | 1 | 2018 | 285 | 0.030 |
Why?
|
Papillomaviridae | 2 | 2013 | 1140 | 0.030 |
Why?
|
Diploidy | 1 | 2016 | 140 | 0.030 |
Why?
|
Leukemia | 1 | 2024 | 1520 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 755 | 0.030 |
Why?
|
Databases, Factual | 1 | 2012 | 8095 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2013 | 1246 | 0.030 |
Why?
|
Chromosome Breakage | 1 | 2016 | 159 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3433 | 0.030 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2015 | 38 | 0.030 |
Why?
|
Child | 6 | 2023 | 80969 | 0.030 |
Why?
|
RNA Transport | 1 | 2015 | 43 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2016 | 221 | 0.030 |
Why?
|
Zebrafish | 2 | 2019 | 3037 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2019 | 1755 | 0.030 |
Why?
|
Models, Biological | 1 | 2012 | 9499 | 0.030 |
Why?
|
Autopsy | 1 | 2019 | 1013 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1337 | 0.030 |
Why?
|
Muscles | 1 | 2020 | 1582 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1855 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8559 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2018 | 864 | 0.030 |
Why?
|
Genetic Association Studies | 2 | 2016 | 2747 | 0.030 |
Why?
|
Biopsy | 2 | 2019 | 6805 | 0.030 |
Why?
|
Anilides | 1 | 2018 | 414 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6856 | 0.030 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2015 | 69 | 0.030 |
Why?
|
Telomere-Binding Proteins | 1 | 2015 | 122 | 0.030 |
Why?
|
Sulfites | 1 | 2014 | 83 | 0.030 |
Why?
|
Tissue Donors | 1 | 2024 | 2382 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 875 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2020 | 11684 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 2016 | 478 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12252 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2015 | 233 | 0.030 |
Why?
|
Prospective Studies | 4 | 2020 | 54950 | 0.030 |
Why?
|
Valine | 1 | 2015 | 410 | 0.030 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2014 | 182 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 948 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1794 | 0.030 |
Why?
|
Endogenous Retroviruses | 1 | 2015 | 112 | 0.030 |
Why?
|
Teratoma | 1 | 2016 | 405 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3056 | 0.030 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2013 | 93 | 0.030 |
Why?
|
Protein Kinases | 1 | 2020 | 1611 | 0.030 |
Why?
|
Liver Failure | 1 | 2015 | 252 | 0.030 |
Why?
|
Germ Cells | 1 | 2017 | 644 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2022 | 1597 | 0.030 |
Why?
|
E1A-Associated p300 Protein | 1 | 2013 | 125 | 0.030 |
Why?
|
Ribosomal Proteins | 1 | 2015 | 370 | 0.030 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2014 | 196 | 0.030 |
Why?
|
Prostatectomy | 1 | 2021 | 1841 | 0.030 |
Why?
|
Binding Sites | 2 | 2015 | 6023 | 0.030 |
Why?
|
Telomerase | 1 | 2018 | 753 | 0.030 |
Why?
|
Pyrrolidinones | 1 | 2013 | 116 | 0.030 |
Why?
|
Adenine | 1 | 2019 | 995 | 0.030 |
Why?
|
Cystectomy | 1 | 2017 | 645 | 0.030 |
Why?
|
Deoxyribonuclease I | 1 | 2013 | 228 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2017 | 1439 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2014 | 387 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2014 | 213 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2019 | 14485 | 0.030 |
Why?
|
Programming Languages | 1 | 2013 | 132 | 0.030 |
Why?
|
Hemoglobins | 1 | 2018 | 1531 | 0.030 |
Why?
|
Topoisomerase Inhibitors | 1 | 2012 | 19 | 0.030 |
Why?
|
Immunity | 1 | 2018 | 1003 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 2013 | 328 | 0.030 |
Why?
|
Up-Regulation | 1 | 2021 | 4148 | 0.020 |
Why?
|
S Phase | 1 | 2013 | 424 | 0.020 |
Why?
|
TCF Transcription Factors | 1 | 2012 | 138 | 0.020 |
Why?
|
Interleukin-3 | 1 | 2013 | 425 | 0.020 |
Why?
|
Haplotypes | 1 | 2018 | 2725 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2016 | 751 | 0.020 |
Why?
|
Risk Factors | 4 | 2022 | 74971 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2023 | 4356 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2013 | 474 | 0.020 |
Why?
|
Neurofibromin 2 | 1 | 2013 | 271 | 0.020 |
Why?
|
Pedigree | 1 | 2019 | 4545 | 0.020 |
Why?
|
Republic of Korea | 1 | 2013 | 592 | 0.020 |
Why?
|
Saliva | 1 | 2016 | 855 | 0.020 |
Why?
|
3T3 Cells | 1 | 2013 | 1085 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2014 | 662 | 0.020 |
Why?
|
Indazoles | 1 | 2013 | 306 | 0.020 |
Why?
|
Molecular Structure | 1 | 2015 | 1885 | 0.020 |
Why?
|
Vietnam | 1 | 2012 | 415 | 0.020 |
Why?
|
Glycolysis | 1 | 2015 | 838 | 0.020 |
Why?
|
Pathology, Molecular | 1 | 2014 | 329 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1675 | 0.020 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2012 | 246 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2014 | 1162 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2013 | 640 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2016 | 1039 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 747 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1683 | 0.020 |
Why?
|
Rare Diseases | 1 | 2016 | 630 | 0.020 |
Why?
|
Leukemia, Myeloid | 1 | 2014 | 693 | 0.020 |
Why?
|
Alcohol Oxidoreductases | 1 | 2011 | 164 | 0.020 |
Why?
|
Neuroglia | 1 | 2016 | 960 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2011 | 411 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1621 | 0.020 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2014 | 827 | 0.020 |
Why?
|
Ribonucleases | 1 | 2011 | 266 | 0.020 |
Why?
|
Culture | 1 | 2014 | 623 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2012 | 628 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2020 | 81892 | 0.020 |
Why?
|
DNA Transposable Elements | 1 | 2014 | 764 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11119 | 0.020 |
Why?
|
Piperidines | 1 | 2019 | 1669 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2018 | 0.020 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 356 | 0.020 |
Why?
|
Retroviridae | 1 | 2012 | 849 | 0.020 |
Why?
|
Mexico | 1 | 2012 | 769 | 0.020 |
Why?
|
Biological Evolution | 1 | 2015 | 1078 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2015 | 1193 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2012 | 384 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6232 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2018 | 2574 | 0.020 |
Why?
|
Piperazines | 1 | 2020 | 2553 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6085 | 0.020 |
Why?
|
Peptides | 1 | 2021 | 4353 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2010 | 286 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2012 | 930 | 0.020 |
Why?
|
Aniline Compounds | 1 | 2015 | 1094 | 0.020 |
Why?
|
Genes, ras | 1 | 2012 | 665 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2016 | 895 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2411 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 1647 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2014 | 968 | 0.020 |
Why?
|
Microfluidics | 1 | 2014 | 674 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2021 | 3408 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 325 | 0.020 |
Why?
|
Child, Preschool | 3 | 2020 | 42684 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39394 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2011 | 751 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2862 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2019 | 2905 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2012 | 725 | 0.020 |
Why?
|
K562 Cells | 1 | 2010 | 648 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6213 | 0.020 |
Why?
|
Systems Integration | 1 | 2010 | 430 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1376 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2827 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 633 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 683 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3076 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2012 | 771 | 0.020 |
Why?
|
Transplantation Conditioning | 1 | 2014 | 1601 | 0.020 |
Why?
|
Intestine, Small | 1 | 2013 | 1218 | 0.020 |
Why?
|
Medical Informatics | 1 | 2014 | 742 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2008 | 277 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2010 | 1002 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2007 | 286 | 0.020 |
Why?
|
DNA Helicases | 1 | 2012 | 854 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2012 | 4168 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4265 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2014 | 1667 | 0.020 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2008 | 259 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2916 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3554 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9564 | 0.020 |
Why?
|
Ligands | 1 | 2013 | 3283 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2011 | 1526 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1197 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10115 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6546 | 0.020 |
Why?
|
Smoking | 2 | 2013 | 9094 | 0.020 |
Why?
|
Indoles | 1 | 2013 | 1836 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12093 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2010 | 1714 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2011 | 1161 | 0.010 |
Why?
|
Prevalence | 1 | 2022 | 15875 | 0.010 |
Why?
|
Infant | 2 | 2020 | 36541 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4413 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2018 | 3982 | 0.010 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2005 | 323 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2015 | 3473 | 0.010 |
Why?
|
Insulin | 1 | 2018 | 6610 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20776 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6991 | 0.010 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2005 | 257 | 0.010 |
Why?
|
Acute Disease | 1 | 2014 | 7245 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2012 | 2820 | 0.010 |
Why?
|
NF-kappa B | 1 | 2011 | 2492 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13510 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 2431 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10641 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8888 | 0.010 |
Why?
|
Cell Movement | 1 | 2012 | 5216 | 0.010 |
Why?
|
Homeostasis | 1 | 2011 | 3348 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2015 | 4363 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4251 | 0.010 |
Why?
|
Astrocytes | 1 | 2006 | 1349 | 0.010 |
Why?
|
Transfection | 1 | 2006 | 5763 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6673 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15471 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10397 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2714 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2011 | 4940 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 26384 | 0.010 |
Why?
|
Aging | 1 | 2015 | 8765 | 0.010 |
Why?
|
Lung | 1 | 2015 | 10097 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40266 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 89247 | 0.010 |
Why?
|
Models, Statistical | 1 | 2006 | 5107 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36861 | 0.000 |
Why?
|
United States | 1 | 2013 | 73180 | 0.000 |
Why?
|